Clincosm LogoSign in Get a demo

stage iiia bladder cancer ajcc v8

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Best Practice
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 18, 2023

Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8 Trial in United States (drug,

Recruiting
  • Bladder Urothelial Carcinoma
  • +3 more
  • Phoenix, Arizona
  • +320 more
Feb 2, 2023

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Lymphadenectomy
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 9, 2023

Stage I Bladder Cancer AJCC v8, Stage II Bladder Cancer AJCC v8, Stage III Bladder Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Stage I Bladder Cancer AJCC v8
  • +4 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

Recruiting
  • Stage II Bladder Cancer AJCC v8
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Los Angeles

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • Quality-of-Life Assessment
  • Vascularized Autograft
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jul 15, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8, Stage II Renal Pelvis Cancer

Completed
Has Results
  • Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
  • +11 more
  • Scottsdale, Arizona
  • +2 more
Mar 12, 2021

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed
Has Results
  • Recurrent Bladder Urothelial Carcinoma
  • +19 more
  • Erlotinib Hydrochloride
  • Houston, Texas
    M D Anderson Cancer Center
Aug 21, 2020